	Contact Us \| Career Opportunities \| Member Login

HOME

ABOUT US

MEMBERSHIP

EVENTS & SERVICES

TRADE & BUSINESS INFO

NEWSROOM

PUBLICATIONS

TRADE & BUSINESS INFO


	Business / Policy Updates
	Business Briefs
	Free Trade Agreements
	Business Opportunities
	Our Partners
	KITA Directory (For SBF Members only)

Home > Trade & Business Info > Business Opportunities

Trade Enquires

Tenders

Trade Enquires

Trade Fairs / Missions / Events

M&A for one of the leading Kazakhstani pharmaceutical distributor

The company in question is one of the five biggest wholesalers of pharmaceuticals in Kazakhstan. Its goal is to promote the most modern pharmaceuticals and innovative medical equipment of high quality in order to diagnose, cure and prevent diseases and illnesses in Kazakhstan. The company is ranked second based on the amount of sales to pharmacies and other retailers of medical products.

The company has a reputation of being a reliable partner to its four thousand clients. It is active in 11 out of 16 regions of the Republic of Kazakhstan. It has 11 office branches, 3 regional representatives and 2 subsidiaries. The company’s sales has increased threefold during the last 5 years.

*An Investment Memorandum shall be provided upon signing of a relative Non Disclosure Agreement and an expressed interest.

Summary of Project	Project Value	Type and Nature of Collaboration	Expertise required from Singapore-based company	Name of Company and Contact person's details
M&A for one of the leading Kazakhstani pharmaceutical distributors.	Around 100 Million Euro	Cooperation within M&A projects. Strategic partnership within the frames of any Kazakhstan related projects.	Project promotion within SBF structure and its network. Investors / funds	Kanat Aubakirov CEO of KAZAKH HOUSE Consulting GmbH Jägerstr. 32 10117 Berlin T: +49 (0)30 75 44 20 51 F: +49 (0)30 75 44 20 53 www.kazakhhouse.de Hans Haller Director of Empacon GmbH Kurfürstenstr. 114, 10787, Berlin T: +49 (0)30 - 219 655 79 F: +49 (0)30 - 275 759 11 www.empaconctc.de

Disclaimer: As with usual business practices, SBF recommends that interested parties exercise due diligence for all the information that is published. SBF does not intend to be the endorsements of, or affiliations with the linked entities.

Note: Information is correct at time of print